                         SEQUENCE LISTING

<110>  Morehouse School of Medicine
 
<120>  ANTIBACTERIAL COMPOSITIONS, METHODS OF MAKING AND USE THEREOF

<130>  1013-496 PCT

<140>  US 16/226,242
<141>  2018-12-19

<150>  US 62/678,002
<151>  2018-05-30

<160>  11     

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Human immunodeficiency virus

<400>  1

Val Gly Phe Pro Val 
1               5   


<210>  2
<211>  5
<212>  PRT
<213>  Simian immunodeficiency virus

<400>  2

Val Gly Val Ser Val 
1               5   


<210>  3
<211>  12
<212>  PRT
<213>  Human immunodeficiency virus

<400>  3

Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val 
1               5                   10          


<210>  4
<211>  12
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  Synthetic

<400>  4

Val Gly Val Ser Val Ala Ala Val Gly Val Ser Val 
1               5                   10          


<210>  5
<211>  20
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  Synthetic

<400>  5

Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val Asp Tyr Lys Asp 
1               5                   10                  15      


Asp Asp Asp Lys 
            20  


<210>  6
<211>  8
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  Synthetic

<400>  6

Asp Tyr Lys Asp Asp Asp Asp Lys 
1               5               


<210>  7
<211>  20
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  Synthetic

<400>  7

Ala Gly Phe Pro Val Ala Ala Ala Gly Phe Pro Val Asp Tyr Lys Asp 
1               5                   10                  15      


Asp Asp Asp Lys 
            20  


<210>  8
<211>  13
<212>  PRT
<213>  Human immunodeficiency virus

<400>  8

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln  
1               5                   10                       


<210>  9
<211>  25
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  Synthetic

<400>  9

Val Gly Phe Pro Val Ala Ala Val Gly Phe Pro Val Gly Arg Lys Lys 
1               5                   10                  15


Arg Arg Gln Arg Arg Arg Pro Pro Gln
            20                  25


<210>  10
<211>  12
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  Synthetic

<400>  10

Ala Gly Phe Pro Val Ala Ala Ala Gly Phe Pro Val 
1               5                   10


<210>  11
<211>  25
<212>  PRT
<213>  ARTIFICIAL SEQUENCE

<220>
<223>  Synthetic

<400>  11

Ala Gly Phe Pro Val Ala Ala Ala Gly Phe Pro Val Gly Arg Lys Lys 
1               5                   10                  15


Arg Arg Gln Arg Arg Arg Pro Pro Gln
            20                  25

          